Tag: "muhc" at biology news

MUHC scientists describe genetic resistance to rampant virus

MUHC researchers have defined genetic resistance to the widespread virus, cytomegalovirus (CMV)--a member of the viral group that causes some of the world's most prevalent diseases, such as herpes, chicken pox and mononucleosis. The groundbreaking research published in Nature Genetics last week, provides a roadmap for the development of human therapies for CMV, which could prolong the life of HIV...

MUHC researchers make cancer target breakthrough

Researchers at the McGill University Health Centre (MUHC), in Montreal, have identified a new gene to combat cancer. In a new study, published in the on-line edition of the journal Clinical Cancer Research this week, the researchers document a reduction in the growth of both colon and lung cancer tumors with inhibition of the gene. . The new target gene is called methylenetetrahydrofolate reducta...

MUHC investigators search for the root of sexual pain in women

A multidisciplinary team consisting of researchers from McGill/MUHC and the CHUM have been awarded a grant of nearly $700,000 by the Canadian Institutes of Health Research (CIHR) to continue their groundbreaking research on pain suffered by some women during sexual intercourse. The new funding will allow the team, consisting of psychologists, gynecologists, physical therapists and statistician/ep...

MUHC announces a transplant first in Quebec

Doctors at the MUHC have announced Quebec's first successful combined heart/liver transplant. The patient, Patrice Dionne, age 54 years, was transferred from the Institut de cardiologie de Quebec (l'hôpital Laval) to the MUHC. The patient received his new heart and liver during a 6-hour operation on April 14, 2006 and was discharged 10 days later. The complex procedure involved 15 physicians, sur...

Rapid oral HIV test shows great promise according to MUHC-led research

A convenient, easy to use, and rapid alternative to blood-based HIV testing may become the new standard for field testing according to a new MUHC study. The study shows that the oral fluid-based OraQuick HIV1/2 test is 100 per cent accurate and patients?preferred choice. . Senior and lead author Dr. Nitika Pai, a postdoctoral fellow at the McGill University Health Centre (MUHC), and her colleag...